Neil W. Gibson, Chief Scientific Officer at Regulus Therapeutics Inc. (RGLS), sold 2,500 shares at $20.41 ($48K) on 2014-10-29, disclosed to the SEC on 2014-10-31.
Scheduled sale ($48k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.68 | 1,100 | $21K | 42.6% |
| 2 | $19.67 | 1,200 | $24K | 48.9% |
| 3 | $20.41 | 200 | $4K | 8.5% |
| Total | $19.29 avg | 2,500 | $48K | 100% |
| Filing → |
| RGLS | SELL | 2014-12-01 | $48K | — | Filing → |
| RGLS | SELL | 2014-10-24 | $48K | — | Filing → |
| RGLS | SELL | 2014-09-15 | $34K | — | Filing → |